The novel locus Prnd is 16 kb downstream of the mouse prion protein (PrP) gene Prnp and encodes a 179 residue PrP-like protein designated doppel (Dpl). Prnd generates major transcripts of 1.7 and 2.7 kb as well as some unusual chimeric transcripts generated by intergenic splicing with Prnp. Like PrP, Dpl mRNA is expressed during embryogenesis but, in contrast to PrP, it is expressed minimally in the CNS. Unexpectedly, Dpl is upregulated in the CNS of two PrP-deficient (Prnp(0/0)) lines of mice, both of which develop late-onset ataxia, suggesting that Dpl may provoke neurodegeneration. Dpl is the first PrP-like protein to be described in mammals, and since Dpl seems to cause neurodegeneration similar to PrP, the linked expression of the Prnp and Prnd genes may play a previously unrecognized role in the pathogenesis of prion diseases or other illnesses.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1006/jmbi.1999.3108 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Loss-of-function mutations in Keratin 32 gene disrupt skin immune homeostasis in pityriasis rubra pilaris.
Nat Commun
July 2024
Hospital for Skin Diseases, Shandong First Medical University, Jinan, Shandong, China.
Article Synopsis
- Pityriasis rubra pilaris (PRP) is a skin condition marked by inflamed, scaly patches, and its exact causes are still not fully understood.
- A study involving 102 PRP patients and 800 healthy individuals found significant links between PRP and mutations in the Keratin 32 gene (KRT32), which helps regulate skin inflammation.
- These findings suggest that KRT32 mutations might contribute to PRP development by leading to increased inflammation, and highlight the potential for KRT32 as a target for new treatments.
Intrinsic determinants of prion protein neurotoxicity in : from sequence to (dys)function.
Front Mol Neurosci
August 2023
Department of Biomedical Sciences, University of Minnesota Medical School, Duluth, MN, United States.
Prion diseases are fatal brain disorders characterized by deposition of insoluble isoforms of the prion protein (PrP). The normal and pathogenic structures of PrP are relatively well known after decades of studies. Yet our current understanding of the intrinsic determinants regulating PrP misfolding are largely missing.
View Article and Find Full Text PDFPityriasis Rubra Pilaris After Moderna COVID-19 Vaccination: A Case Report and Literature Review.
Am J Dermatopathol
March 2023
Departments of Pathology, and.
To date, over 60% of the world's population has received at least 1 dose of coronavirus disease 2019 (COVID-19) vaccination, with over 12 billion doses administered globally. Commonly reported adverse effects of COVID-19 vaccination include fever, headache, myalgia, and injection site reactions. The spectrum of documented cutaneous reactions after COVID-19 vaccination is broad; however, pityriasis rubra pilaris (PRP) or PRP-like eruption secondary to COVID-19 vaccine is exceedingly rare, with only 17 cases previously reported to date in the English literature.
View Article and Find Full Text PDFPityriasis rubra pilaris-like eruption following administration of the BNT163b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine.
Clin Exp Dermatol
January 2022
Department of Dermatology, Solihull Hospital, University Hospitals Birmingham Foundation NHS Trust, Birmingham, UK.
We describe a case of a pityriasis rubra pilaris (PRP)-like eruption occurring following administration of the Pfizer-Biontech mRNA COVID-19 vaccine, with worsening of the condition following the second dose. To our knowledge, this is the first reported case of a PRP-like eruption as a cutaneous adverse event of the Pfizer-Biontech mRNA COVID-19 vaccine.
View Article and Find Full Text PDFProteasomal Inhibition Redirects the PrP-Like Shadoo Protein to the Nucleus.
Mol Neurobiol
November 2019
Centre for Prions and Protein Folding Diseases, University of Alberta, 204 Brain and Aging Research Building, Edmonton, Alberta, T6G 2M8, Canada.
The Shadoo protein (Sho) exhibits homology to the hydrophobic region of the cellular isoform of prion protein (PrP). As prion-infected brains gradually accumulate infectivity-associated isoforms of prion protein (PrP), levels of mature endogenous Sho become reduced. To study the regulatory effect of the proteostatic network on Sho expression, we investigated the action of lactacystin, MG132, NHCl, and 3-methyladenine (3-MA) in two cell culture models.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!